RxDoctor Payments Data

Shyam Srinivas

Nuclear Radiology · Stanford, CANPI 1194739425

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Progenics Pharmaceuticals, Inc. at 33.7% of the total. 2025 is the largest year on record at $7,903, more than ten times the $144 reported in 2019.

$25,077in general payments, 2019–2025

Across 56 payments — averaging $447.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Progenics Pharmaceuticals, Inc.$8K
  • Telix Pharmaceuticals$7K
  • GE HealthCare$4K
  • Advanced Accelerator Applications$3K
  • Blue Earth Diagnostics$2K
  • Sirtex Medical Inc$560
  • plus $564 from 5 others
$10,124in research payments, 2019–2025

Across 24 payments — averaging $421.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AVEO Pharmaceuticals, Inc.$7K
  • Telix Pharmaceuticals$3K
  • Siemens Medical Solutions USA, Inc.$29

What the payments were for

  • Consulting fees$8,87535%
  • Speaking & faculty fees$11,86547%
  • Travel & lodging$2,54510%
  • Food & beverage$1,7887%
  • Education$40%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,077 in reported general payments places this provider in the 80th percentile of 42 nuclear radiology providers in California.

See all nuclear radiology providers in California

Medicare billing

Part B allowed, 2024
$158,764
Medicare patients
616
Services billed
706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear radiology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →